The cell lines selected represent prevalent types of breast cancer, i.e., steroid hormone receptor-positive disease that overexpresses Her2/Neu (BT474) and two steroid hormone receptor-negative molecular subtypes that vary in Her2/Neu expression status. This evidence concerns the gene ERBB2 and breast carcinoma.